Virbac Group, a leading player in the global animal health industry, is headquartered in France and operates extensively across Europe, North America, and Asia. Founded in 1964, the company has established itself as a trusted provider of veterinary products and services, focusing on the health and well-being of companion animals and livestock. Virbac's core offerings include vaccines, pharmaceuticals, and nutritional products, all designed to enhance animal health and productivity. What sets Virbac apart is its commitment to research and development, ensuring innovative solutions tailored to the evolving needs of veterinarians and pet owners alike. With a strong market position, Virbac has achieved notable milestones, including a robust international presence and a diverse product portfolio that reflects its dedication to quality and efficacy in animal care.
How does Virbac group's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Virbac group's score of 31 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Virbac Group reported total carbon emissions of approximately 23,727,000 kg CO2e, all of which fall under Scope 1 emissions. This marks an increase from 20,814,000 kg CO2e in 2021 and 21,007,000 kg CO2e in 2020. The company has not disclosed any Scope 2 or Scope 3 emissions data for these years. Virbac's emissions data from 2014 indicates a more comprehensive reporting approach, with total emissions of 15,014,000 kg CO2e from Scope 2 and 6,818,000 kg CO2e from Scope 3, alongside 19,186,000 kg CO2e from Scope 1. This earlier data highlights the company's broader emissions profile, including significant contributions from purchased goods and services. Despite the lack of specific reduction targets or commitments, Virbac is actively engaged in climate initiatives, as evidenced by their participation in the CDP. However, no specific science-based targets (SBTi) or documented reduction initiatives have been reported. Overall, while Virbac has shown a commitment to transparency in emissions reporting, the absence of reduction targets suggests an opportunity for further climate action and commitment to sustainability.
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 19,186,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 15,014,000 | - | - | - |
| Scope 3 | 6,818,000 | - | - | - |
Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 17% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the primary emissions source at 73% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Virbac group has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
